Nurse staffing and patient outcomes: Strengths and limitations of the evidence to inform policy and practice. A review and discussion paper based on evidence …
A large and increasing number of studies have reported a relationship between low nurse
staffing levels and adverse outcomes, including higher mortality rates. Despite the evidence …
staffing levels and adverse outcomes, including higher mortality rates. Despite the evidence …
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised …
Background Evidence of comparative benefits of long-acting injectable antipsychotics (LAIs)
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …
[HTML][HTML] Good practices for realworld data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPORISPE Special Task Force on …
Purpose Realworld evidence (RWE) includes data from retrospective or prospective
observational studies and observational registries and provides insights beyond those …
observational studies and observational registries and provides insights beyond those …
Quasi-experimental design
ML Maciejewski - Biostatistics & Epidemiology, 2020 - Taylor & Francis
Quasi-experiments are similar to randomized controlled trials in many respects, but there are
many challenges in designing and conducting a quasi-experiment when internal validity …
many challenges in designing and conducting a quasi-experiment when internal validity …
State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force–3
State-transition modeling (STM) is an intuitive, flexible, and transparent approach of
computer-based decision-analytic modeling, including both Markov model cohort simulation …
computer-based decision-analytic modeling, including both Markov model cohort simulation …
[HTML][HTML] Improving transparency to build trust in real-world secondary data studies for hypothesis testing—why, what, and how: recommendations and a road map from …
Real-world data (RWD) and the derivations of these data into real-world evidence (RWE)
are rapidly expanding from informing healthcare decisions at the patient and health system …
are rapidly expanding from informing healthcare decisions at the patient and health system …
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral …
V Allan, SV Ramagopalan… - Journal of …, 2020 - becarispublishing.com
After decades of warfarin being the only oral anticoagulant (OAC) widely available for stroke
prevention in atrial fibrillation, four direct OACs (apixaban, dabigatran, edoxaban and …
prevention in atrial fibrillation, four direct OACs (apixaban, dabigatran, edoxaban and …
[HTML][HTML] HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: a good practices report …
Objectives Ambiguity in communication of key study parameters limits the utility of real-world
evidence (RWE) studies in healthcare decision-making. Clear communication about data …
evidence (RWE) studies in healthcare decision-making. Clear communication about data …
[HTML][HTML] Performance-based risk-sharing arrangements—good practices for design, implementation, and evaluation: report of the ISPOR good practices for …
There is a significant and growing interest among both payers and producers of medical
products for agreements that involve a “pay-for-performance” or “risk-sharing” element …
products for agreements that involve a “pay-for-performance” or “risk-sharing” element …
Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data …
ML Berger, M Mamdani, D Atkins… - Value in health, 2009 - Wiley Online Library
Objectives: Health insurers, physicians, and patients worldwide need information on the
comparative effectiveness and safety of prescription drugs in routine care. Nonrandomized …
comparative effectiveness and safety of prescription drugs in routine care. Nonrandomized …